CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has called for redemption on March 1, 2007, all of its outstanding 5% Convertible Subordinated Debentures due September 1, 2013, at a 1% call premium plus accrued interest. At January 29, 2007, there were approximately $1.5 million of principal amount of such debentures outstanding.
